Search

Search Constraints

You searched for: Author/Creator Hess, Georg

Search Results

1. A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial. (1st April 2022)

2. Associations of ofatumumab exposure and treatment outcomes in patients with untreated CLL receiving chemoimmunotherapy. Issue 2 (1st February 2017)

3. Biological variation of the cardiac index in patients with stable chronic heart failure: inert gas rebreathing compared with impedance cardiography†. (15th June 2015)

4. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Issue 5 (May 2016)

5. Comparison of two doses of intravenous temsirolimus in patients with relapsed/refractory mantle cell lymphoma. Issue 3 (4th March 2018)

6. Cost-effectiveness analysis of KTE-X19 CAR T therapy versus real-world standard of care in patients with relapsed/refractory mantle cell lymphoma post BTKi in England. (31st December 2022)

7. Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphoma. Issue 11 (18th September 2020)

8. FCR front-line therapy and quality of life in patients with chronic lymphocytic leukemia. Issue 2 (1st February 2017)

9. Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma. Issue 3 (8th June 2020)

10. Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus. Issue 12 (2nd December 2017)